Variant report
Variant | nsv611375 |
---|---|
Chromosome Location | chr8:54122620-54130075 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NPBWR1-1 | chr8:54128859-54128983 | ENSG00000254687.1 |
2 | lnc-NPBWR1-1 | chr8:54128859-54129064 | ENSG00000254687.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577932399 | chr8:54125233-54125234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567203298 | chr8:54125246-54125247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191858604 | chr8:54125269-54125270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557442699 | chr8:54125293-54125294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182524084 | chr8:54125294-54125295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574230095 | chr8:54125336-54125337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188780017 | chr8:54125339-54125340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35572591 | chr8:54125344-54125345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs117368889 | chr8:54125355-54125356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546584864 | chr8:54125358-54125359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192875720 | chr8:54125388-54125389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117908069 | chr8:54125401-54125402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545654880 | chr8:54125412-54125413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543216684 | chr8:54125472-54125473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373848885 | chr8:54125559-54125560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185161902 | chr8:54125598-54125599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147448057 | chr8:54125613-54125614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543019512 | chr8:54125631-54125632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190387231 | chr8:54125672-54125673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6990826 | chr8:54125673-54125674 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs139881457 | chr8:54125674-54125675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539367162 | chr8:54125708-54125709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565897760 | chr8:54125709-54125710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559288439 | chr8:54125714-54125715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75273631 | chr8:54125765-54125766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551608719 | chr8:54125803-54125804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73601364 | chr8:54125832-54125833 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs192374073 | chr8:54125851-54125852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183929875 | chr8:54125860-54125861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557430235 | chr8:54125861-54125862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs58882388 | chr8:54125920-54125921 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs115696815 | chr8:54125934-54125935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188273223 | chr8:54125937-54125938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142951178 | chr8:54125945-54125946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2114103 | chr8:54125974-54125975 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs544943103 | chr8:54126014-54126015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112348335 | chr8:54126032-54126033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564796706 | chr8:54126033-54126034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543007389 | chr8:54126056-54126057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181365655 | chr8:54126074-54126075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73601368 | chr8:54126075-54126076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs569817608 | chr8:54126088-54126089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150704235 | chr8:54126103-54126104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139869980 | chr8:54126131-54126132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528240541 | chr8:54126176-54126177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185640096 | chr8:54126223-54126224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571554881 | chr8:54126303-54126304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530859189 | chr8:54126314-54126315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550473727 | chr8:54126357-54126358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76124919 | chr8:54126385-54126386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:54125200-54126800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:54126600-54128200 | Enhancers | Placenta | Placenta |
3 | chr8:54126800-54127600 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr8:54127000-54127800 | ZNF genes & repeats | Spleen | Spleen |
5 | chr8:54127600-54136400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:54127800-54128000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr8:54127800-54129400 | Weak transcription | Spleen | Spleen |
8 | chr8:54128800-54129200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:54129000-54129200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr8:54129000-54129200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr8:54129200-54130200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:54129200-54131200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr8:54129600-54131000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr8:54130000-54130200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr8:54130000-54130400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr8:54130000-54132000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |